Investor Presentaiton slide image

Investor Presentaiton

Company overview Financial performance Financial review Appendix 2022 priorities Appendix Innovation: Pipeline overview Innovation: Clinical trials References Abbreviations 30 Investor Relations | Q2 2022 Results NOVARTIS | Reimagining Medicine
View entire presentation